The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according to the manufacturer.Genentech said in a press release that TNKase ...
Pleasanton, California - BosterBio's expertise in antibody production and its exceptional technical support and educational ...
India: Emerging evidence highlights the potential role of serum soluble urokinase-type plasminogen activator receptor (suPAR) as a valuable biomarker for diagnosing and monitoring chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback